Prospective Evaluation of WHO and European Clinical, Molecular and Pathological (WHO-ECMP) Criteria for Myeloproliferative Neoplasms (MPN) of Various Molecular Etiology: Characteristics of JAK2V617F, MPL515 and CALR Mutated MPN
Journal of Hematology and Blood Disorders · 2015
DOI: 10.15744/2455-7641.1.104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematology and Blood Disorders, 2015. Verfasst von Michiels JJ und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
JJ, M., T, D., K, F., FA, V., V, P., K, S., & HD, R. (2015). Prospective Evaluation of WHO and European Clinical, Molecular and Pathological (WHO-ECMP) Criteria for Myeloproliferative Neoplasms (MPN) of Various Molecular Etiology: Characteristics of JAK2V617F, MPL515 and CALR Mutated MPN. Journal of Hematology and Blood Disorders. https://doi.org/10.15744/2455-7641.1.104
Vancouver
JJ M, T D, K F, FA V, V P, K S, et al. Prospective Evaluation of WHO and European Clinical, Molecular and Pathological (WHO-ECMP) Criteria for Myeloproliferative Neoplasms (MPN) of Various Molecular Etiology: Characteristics of JAK2V617F, MPL515 and CALR Mutated MPN. Journal of Hematology and Blood Disorders. 2015. doi:10.15744/2455-7641.1.104
BibTeX
@article{JJ2015,
author = {JJ, Michiels and T, Devos and K, Fostier and FA, Valster and V, Potters and K, Schelfout and HD, Raeve},
title = {Prospective Evaluation of WHO and European Clinical, Molecular and Pathological (WHO-ECMP) Criteria for Myeloproliferative Neoplasms (MPN) of Various Molecular Etiology: Characteristics of JAK2V617F, MPL515 and CALR Mutated MPN},
journal = {Journal of Hematology and Blood Disorders},
year = {2015},
doi = {10.15744/2455-7641.1.104}
}
EUVIMED